Desarrollo y aplicación de cuidados de la salud ; Development and application of health care.
DACUS
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (8)
2024
-
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology, Vol. 79, Núm. 1, pp. 135-148
2022
-
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
Hepatology, Vol. 76, Núm. 4, pp. 1121-1134
2018
-
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts
Hepatology Communications, Vol. 2, Núm. 7, pp. 807-820
2017
-
Deregulated neddylation in liver fibrosis
Hepatology, Vol. 65, Núm. 2, pp. 694-709
-
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
Gastroenterology, Vol. 152, Núm. 6, pp. 1449-1461.e7
2013
-
Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease
Hepatology, Vol. 57, Núm. 2, pp. 505-514
2012
-
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
Journal of Proteome Research, Vol. 11, Núm. 4, pp. 2521-2532
2010
-
Non-alcoholic fatty liver disease proteomics
Proteomics - Clinical Applications, Vol. 4, Núm. 4, pp. 362-371